Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo Qiu

Showing results (531-540 of 648) with videos related to

Pageof 65
Sort By:
Nature|July 22, 2014
Fructose-1,6-bisphosphatase opposes renal carcinoma progressionBo Li, Bo Qiu, David S M Lee, et al.
Annals of Surgical Oncology|February 19, 2016
Epidermal Growth Factor Receptor Mutation Status and Treatment Outcome for R0-Resected Patients with Stage 3 Non-small Cell Lung CancerSong Ran Liu, Bo Qiu, Hong Yang, et al.
Cancer|December 15, 2025
Magnetic resonance-guided split-course hypo-fractionated radiotherapy with concurrent chemotherapy and consolidative immunotherapy in locally advanced non-small cell lung cancer: A single arm, phase 2 studyPengXin Zhang, DaQuan Wang, ShaoHan Yin, et al.
Journal of Applied Toxicology : JAT|May 10, 2025
Safety and Toxicity of Qi-Fu Yin, a Classical Traditional Chinese Medicine Prescription: A Nonclinical ResearchKai Chen, Xuemin Yao, Ying Yu, et al.
Journal of Cancer|April 4, 2017
TNM Staging Matched-pair Comparison of Surgery After Neoadjuvant Chemoradiotherapy, Surgery Alone and Definitive Chemoradiotherapy for Thoracic Esophageal Squamous Cell CarcinomaShiLiang Liu, Bo Qiu, GuangYu Luo, et al.
Zhonghua Nei Ke Za Zhi|July 26, 2011
[A pilot study of diaphragmatic function evaluated as predictors of weaning in chronic obstructive pulmonary disease patients]Huo-Gen Liu, Ling Liu, Rui Tang, et al.
Frontiers in Oncology|January 3, 2022
Efficacy and Safety of Docetaxel and Sodium Cantharidinate Combination <i>vs.</i> Either Agent Alone as Second-Line Treatment for Advanced/Metastatic NSCLC With Wild-Type or Unknown EGFR Status: An Open-Label, Randomized Controlled, Prospective, Multi-Center Phase III Trial (Cando-L1)Lin Wu, Chao Deng, Hui Zhang, et al.
Oncogene|April 16, 2022
Wnt-TCF7-SOX9 axis promotes cholangiocarcinoma proliferation and pemigatinib resistance in a FGF7-FGFR2 autocrine pathwayZengli Liu, Jialiang Liu, Tianli Chen, et al.
Journal for Immunotherapy of Cancer|June 23, 2024
Correlation of K<sup>trans</sup> derived from dynamic contrast-enhanced MRI with treatment response and survival in locally advanced NSCLC patients undergoing induction immunochemotherapy and concurrent chemoradiotherapyDaQuan Wang, SongRan Liu, Jia Fu, et al.
Zhonghua Yi Xue Za Zhi|July 22, 2010
[Effect of endothelial nitric oxide synthase gene polymorphisms upon disease severity and outcome in septic patients]Ying Zhu, Hai-bo Qiu, Jing-tao Liu, et al.
Pageof 65

Showing results (531-540 of 648) with videos related to

Sort By:
Pageof 65
Nature|July 22, 2014
Fructose-1,6-bisphosphatase opposes renal carcinoma progressionBo Li, Bo Qiu, David S M Lee, et al.
Annals of Surgical Oncology|February 19, 2016
Epidermal Growth Factor Receptor Mutation Status and Treatment Outcome for R0-Resected Patients with Stage 3 Non-small Cell Lung CancerSong Ran Liu, Bo Qiu, Hong Yang, et al.
Cancer|December 15, 2025
Magnetic resonance-guided split-course hypo-fractionated radiotherapy with concurrent chemotherapy and consolidative immunotherapy in locally advanced non-small cell lung cancer: A single arm, phase 2 studyPengXin Zhang, DaQuan Wang, ShaoHan Yin, et al.
Journal of Applied Toxicology : JAT|May 10, 2025
Safety and Toxicity of Qi-Fu Yin, a Classical Traditional Chinese Medicine Prescription: A Nonclinical ResearchKai Chen, Xuemin Yao, Ying Yu, et al.
Journal of Cancer|April 4, 2017
TNM Staging Matched-pair Comparison of Surgery After Neoadjuvant Chemoradiotherapy, Surgery Alone and Definitive Chemoradiotherapy for Thoracic Esophageal Squamous Cell CarcinomaShiLiang Liu, Bo Qiu, GuangYu Luo, et al.
Zhonghua Nei Ke Za Zhi|July 26, 2011
[A pilot study of diaphragmatic function evaluated as predictors of weaning in chronic obstructive pulmonary disease patients]Huo-Gen Liu, Ling Liu, Rui Tang, et al.
Frontiers in Oncology|January 3, 2022
Efficacy and Safety of Docetaxel and Sodium Cantharidinate Combination <i>vs.</i> Either Agent Alone as Second-Line Treatment for Advanced/Metastatic NSCLC With Wild-Type or Unknown EGFR Status: An Open-Label, Randomized Controlled, Prospective, Multi-Center Phase III Trial (Cando-L1)Lin Wu, Chao Deng, Hui Zhang, et al.
Oncogene|April 16, 2022
Wnt-TCF7-SOX9 axis promotes cholangiocarcinoma proliferation and pemigatinib resistance in a FGF7-FGFR2 autocrine pathwayZengli Liu, Jialiang Liu, Tianli Chen, et al.
Journal for Immunotherapy of Cancer|June 23, 2024
Correlation of K<sup>trans</sup> derived from dynamic contrast-enhanced MRI with treatment response and survival in locally advanced NSCLC patients undergoing induction immunochemotherapy and concurrent chemoradiotherapyDaQuan Wang, SongRan Liu, Jia Fu, et al.
Zhonghua Yi Xue Za Zhi|July 22, 2010
[Effect of endothelial nitric oxide synthase gene polymorphisms upon disease severity and outcome in septic patients]Ying Zhu, Hai-bo Qiu, Jing-tao Liu, et al.
Pageof 65